                         SEQUENCE LISTING

<110>  UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF 
       HIGHER EDUCATION
 
<120>  USE OF MICROPEROXIDASES FOR THE TREATMENT OF 
       CARBOXYHEMOGLOBINEMIA

<130>  8123-92829-02

<150>  US 62/001,754
<151>  2014-05-22

<160>  10    

<170>  PatentIn version 3.5

<210>  1
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(3)
<223>  Xaa = any natural or non-canonical amino acid

<400>  1

Cys Xaa Xaa Cys His 
1               5   


<210>  2
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa = 1 to 20 residues of any combination of natural or 
       non-canonical amino acids

<220>
<221>  MISC_FEATURE
<222>  (3)..(4)
<223>  Xaa = any natural or non-canonical amino acid

<400>  2

Xaa Cys Xaa Xaa Cys His 
1               5       


<210>  3
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa = 1 to 20 residues of any combination of natural or 
       non-canonical amino acids

<220>
<221>  MISC_FEATURE
<222>  (3)..(4)
<223>  Xaa = any natural or non-canonical amino acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa = 1 to 20 residues of any combination of natural or 
       non-canonical amino acids

<400>  3

Xaa Cys Xaa Xaa Cys His Xaa 
1               5           


<210>  4
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  4

Val Gln Lys Cys Ala Gln Cys His Thr Val Glu 
1               5                   10      


<210>  5
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  5

Cys Ala Gln Cys His Thr 
1               5       


<210>  6
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  6

Cys Ala Gln Cys His Thr Val Glu 
1               5               


<210>  7
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  7

Lys Cys Ala Gln Cys His Thr Val Glu 
1               5                   


<210>  8
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  8

Cys Lys Ala Cys His Met Val Gln Ala Pro Asp Gly Thr Asp Ile Val 
1               5                   10                  15      


Lys 
    


<210>  9
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  9

Gly Asp Val Glu Lys Gly Lys Lys Ile Phe Ile Met Lys Cys Ser Gln 
1               5                   10                  15      


Cys His Thr Val Glu 
            20      


<210>  10
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  10

Gly Asp Val Glu Lys Gly Lys Lys Ile Phe Val Gln Lys Cys Ala Gln 
1               5                   10                  15      


Cys His Thr Val Glu 
            20      


